Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older
- People who are Qatari or of Arab background
- People who have been admitted to hospital for a serious heart condition, either a sudden blockage or reduced blood flow to the heart (Acute Coronary Syndrome), or a sudden worsening of heart failure (Acute Heart Failure)
- People who have diabetes (measured by a blood sugar level marker called HbA1c of 6.5% or higher, or any HbA1c level if the person is already taking medication to manage blood sugar) or pre-diabetes (HbA1c between 5.7% and 6.4%)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are not Qatari or not of Arab background
- People who do not have diabetes or pre-diabetes, meaning their HbA1c blood sugar marker is below 5.7%
- This trial is a review of existing medical records and does not involve any direct contact with individuals; people who are incarcerated are not a focus of this study, and incarceration status cannot be identified from the records being reviewed (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charbel Abi Khalil, Weill Cornell Medicine-Qatar
Phone: + 974 4492 8484
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of 3-point Major Adverse Cardiovascular Events (MACE) in Acute Coronary Syndrome Patients; Incidences of 2-point Major Adverse Cardiovascular Events (MACE) in Heart Failure Patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.